Literature DB >> 30849686

Perinatal complications in female survivors of cancer: a systematic review and meta-analysis.

Anne-Lotte L F van der Kooi1, Tom W Kelsey2, Marry M van den Heuvel-Eibrink3, Joop S E Laven4, W Hamish B Wallace5, Richard A Anderson6.   

Abstract

BACKGROUND: Observational studies have suggested that perinatal outcomes are worse in offspring of cancer survivors. We conducted a systematic review and meta-analysis to examine the risks of perinatal complications in female cancer survivors diagnosed before the age of 40 years.
METHODS: All published articles on pregnancy, perinatal or congenital risks in female cancer survivors were screened for eligibility. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed.
RESULTS: Twenty-two studies met the inclusion criteria. Meta-analysis indicates that offspring of cancer survivors are at increased risk of prematurity (relative risk [RR]: 1.56; 95% confidence interval [CI] 1.37-1.77) and low birth weight (RR 1.47; 95% CI 1.24-1.73) but not of being small for gestational age (RR 0.99; 95% CI 0.81-1.22). Cancer survivors have higher rates of elective (RR: 1.38; 95% CI 1.13-1.70) and emergency caesarean section (RR: 1.22; 95% CI 1.15-1.30) as well as assisted vaginal delivery (RR: 1.10; 95% CI 1.02-1.18) and are at increased risk of postpartum haemorrhage (RR: 1.18; 95% CI 1.02-1.36). The risk of congenital abnormalities also appears increased (RR 1.10; 95% CI 1.02-1.20), but this is likely to be an artefact of analysis. Although meta-analysis of the effects of radiotherapy was not possible for all outcomes, there was an increased risk of prematurity (RR 2.27; 95% CI 1.34-3.82) and consistent findings of low birth weight (RR 1.38-2.31). Risk of being small for gestational age was increased only after high uterine radiotherapy dosage.
CONCLUSION: The increased perinatal risks warrant a proactive approach from healthcare providers in both counselling and management of perinatal care for cancer survivors.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Cancer survivors; Congenital abnormalities; Low birth weight; Perinatal risk; Postpartum haemorrhage; Premature delivery

Mesh:

Year:  2019        PMID: 30849686     DOI: 10.1016/j.ejca.2019.01.104

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  9 in total

1.  Enhancing Evidence for Preconception and Prenatal Counseling on Obstetrical Risks After Cancer.

Authors:  Hazel B Nichols; Daniel M Green
Journal:  J Natl Cancer Inst       Date:  2022-04-11       Impact factor: 13.506

2.  Clinical summary guide: reproduction in women with previous abdominopelvic radiotherapy or total body irradiation.

Authors:  G Rozen; P Rogers; S Chander; R Anderson; O McNally; M Umstad; A Winship; K Hutt; W T Teh; A Dobrotwir; R Hart; W Ledger; K Stern
Journal:  Hum Reprod Open       Date:  2020-10-25

3.  Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function.

Authors:  Anne-Lotte L F van der Kooi; Marloes van Dijk; Linda Broer; Marleen H van den Berg; Joop S E Laven; Flora E van Leeuwen; Cornelis B Lambalk; Annelies Overbeek; Jacqueline J Loonen; Helena J van der Pal; Wim J Tissing; Birgitta Versluys; Dorine Bresters; Catharina C M Beerendonk; Cécile R Ronckers; Margriet van der Heiden-van der Loo; Gertjan L Kaspers; Andrica C H de Vries; Leslie L Robison; Melissa M Hudson; Wassim Chemaitilly; Julianne Byrne; Claire Berger; Eva Clemens; Uta Dirksen; Jeanette Falck Winther; Sophie D Fosså; Desiree Grabow; Riccardo Haupt; Melanie Kaiser; Tomas Kepak; Jarmila Kruseova; Dalit Modan-Moses; Saskia M F Pluijm; Claudia Spix; Oliver Zolk; Peter Kaatsch; Jesse H Krijthe; Leontien C Kremer; Yutaka Yasui; Russell J Brooke; André G Uitterlinden; Marry M van den Heuvel-Eibrink; Eline van Dulmen-den Broeder
Journal:  Hum Reprod       Date:  2021-03-18       Impact factor: 6.918

4.  Family size and duration of fertility in female cancer survivors: a population-based analysis.

Authors:  Richard A Anderson; Tom W Kelsey; David S Morrison; W Hamish B Wallace
Journal:  Fertil Steril       Date:  2021-12-20       Impact factor: 7.329

5.  Effects of early maternal cancer and fertility treatment on the risk of adverse birth outcomes.

Authors:  Cathrine Everhøj; Filippa Nyboe Norsker; Catherine Rechnitzer; Sofie de Fine Licht; Thomas T Nielsen; Susanne K Kjær; Allan Jensen; Marie Hargreave; Jane Christensen; Federica Belmonte; Stine Kjaer Urhoj; Katrine Strandberg-Larsen; Jeanette F Winther; Line Kenborg
Journal:  EClinicalMedicine       Date:  2022-04-04

6.  The Use of Assisted Reproductive Technology by European Childhood Cancer Survivors.

Authors:  Anja Borgmann-Staudt; Simon Michael; Greta Sommerhaeuser; Marta-Julia Fernández-González; Lucía Alacán Friedrich; Stephanie Klco-Brosius; Tomas Kepak; Jarmila Kruseova; Gisela Michel; Anna Panasiuk; Sandrin Schmidt; Laura Lotz; Magdalena Balcerek
Journal:  Curr Oncol       Date:  2022-08-15       Impact factor: 3.109

7.  Obstetric and perinatal outcomes in female survivors of childhood or adolescent cancer: Protocol of a meta-analysis of population-based cohort studies.

Authors:  Fang Deng; Xiuan Gao; Limian Xu; Weijie Li; Zubing Mei; Caijun Xie
Journal:  PLoS One       Date:  2022-09-02       Impact factor: 3.752

8.  The Adolescent and Young Adult (AYA) Horizon Study: An AYA Cancer Survivorship Cohort.

Authors:  Chun R Chao; Lawrence H Kushi; Hazel B Nichols; Chris D Baggett; Stephanie M Engel; Darios Getahun; Chelsea Anderson; Nancy T Cannizzaro; Laura Green; Parul Gupta; Cecile A Laurent; Paul C Lin; Clare Meernik; Lisa M Moy; Ethan Wantman; Lanfang Xu; Marilyn L Kwan; Jennifer E Mersereau
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-02-22       Impact factor: 4.090

Review 9.  Gender-specific aspects related to type of fertility preservation strategies and access to fertility care.

Authors:  Marta Perachino; Claudia Massarotti; Maria Grazia Razeti; Francesca Parisi; Luca Arecco; Alessandra Damassi; Piero Fregatti; Cinzia Solinas; Matteo Lambertini
Journal:  ESMO Open       Date:  2020-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.